Evidence map›Paper›PMID 25882666›Full record

ArticleCytotherapy2015

Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment.

Jiaqiang Ren, Huan Wang, Katherine Tran, Sara Civini, Ping Jin, Luciano Castiello, Ji Feng, Sergei A Kuznetsov, Pamela G Robey, Marianna Sabatino and 1 more

Abstract read
In one paragraph

Article in Cytotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cellular Heterogeneity of Mesenchymal Stem/Stromal Cells in the Bone Marrow.Frontiers in cell and developmental biology · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. International journal of dentistry · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jiaqiang RenDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Huan WangDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Katherine TranDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Sara CiviniDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Ping JinDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Luciano CastielloDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Ji FengDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Sergei A KuznetsovCraniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Pamela G RobeyCraniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Marianna SabatinoDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
David F StroncekDepartment of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: dstroncek@cc.nih.gov.
National Institutes of Health Clinical Center · USNational Institutes of Health · US

Funding

The role of stem cells in skeletal health and diseaseZIADE000380 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI ROBEY, PAMELA G · 2009 to 2025
$30.6M
Develop novel assays for assessing cellular and gene therapiesZIACL002119 · CLC · CLINICAL CENTER · PI STRONCEK, DAVID · 2010 to 2025
$0k
Development of novel cell and gene therapiesZIACL002120 · CLC · CLINICAL CENTER · PI STRONCEK, DAVID · 2009 to 2025
$0k
Intramural NIH HHS ZIA CL002119Intramural NIH HHS ZIA CL002120
6 · The paper itself

Abstract

BACKGROUND

aimsEx vivo expansion and serial passage of human bone marrow stromal cells (BMSCs, also known as bone marrow-derived mesenchymal stem cells) is required to obtain sufficient quantities for clinical therapy. The BMSC confluence criteria used to determine passage and harvest timing vary widely, and the impact of confluence on BMSC properties remains controversial. The effects of confluence on BMSC properties were studied and confluence-associated markers were identified.

methodsBMSC characteristics were analyzed as they grew from 50% to 100% confluence, including viability, population doubling time, apoptosis, colony formation, immunosuppression, surface marker expression, global gene expression and microRNA expression. In addition, culture supernatant protein, glucose, lactate and pH levels were analyzed.

resultsConfluence-dependent changes were detected in the expression of several cell surface markers: 39 culture supernatant proteins, 26 microRNAs and 2078 genes. Many of these surface markers, proteins, microRNAs and genes have been reported to be important in BMSC function. The pigment epithelium-derived factor/vascular endothelial growth factor ratio increased with confluence, but 80% and 100% confluent BMSCs demonstrated a similar level of immunosuppression of mixed lymphocyte reactions. In addition, changes in lactate and glucose levels correlated with BMSC density.

conclusionsBMSC characteristics change as confluence increases. 100% confluent BMSCs may have compromised pro-angiogenesis properties but may retain their immunomodulatory properties. Supernatant lactate and glucose levels can be used to estimate confluence and ensure consistency in passage and harvest timing. Flow cytometry or microRNA expression can be used to confirm that the BMSCs have been harvested at the appropriate confluence.

Indexed as

Cell Culture TechniquesApoptosisBiomarkersBone Marrow CellsCell- and Tissue-Based TherapyCell ProliferationCells, CulturedEye ProteinsFlow CytometryGene ExpressionGene Expression ProfilingGlucoseHumansLactic AcidMaleMembrane ProteinsBiomarkersEye ProteinsGlucoseLactic AcidMembrane ProteinsMicroRNAsNerve Growth FactorsPigment Epithelium-Derived FactorSerpinsVascular Endothelial Growth Factor Abone marrow stromal cellscellular therapyconfluencegene expression profilingmicroRNA

Identifiers

PMID25882666
PMCPMC4461557
OpenAlexW2000161822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.